Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.

Clinical trial NCT00385138 · TERMINATED

Trial details

NCT number: NCT00385138
Sponsor: The Medicines Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis Acute Coronary Syndrome (ACS)

Start date: 2006-09-01
Primary completion: 2009-05-01
Enrollment: 5364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.